A sharp increase in the price of the gout drug colchicine led to lower use and poorer disease control, UCLA research suggests
Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly […]
